Skip to content

Insider · CIK 0001910985

Bharucha David

Reports to the SEC for 1 company · MONTREAL, A8

Transactions

18

Companies

1

Filings

8

CIK

0001910985

Forms 4 and 5

Insider transactions

18 trades
DateCompanyValue
2026-02-02MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award—
2026-02-02MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award—
2026-02-02MISTMilestone Pharmaceuticals Inc. · Restricted Stock UnitA Award—
2026-01-26MISTMilestone Pharmaceuticals Inc. · Restricted Stock UnitsM Exercise/Conversion—
2026-01-26MISTMilestone Pharmaceuticals Inc.S Sale−$23.6K
2026-01-26MISTMilestone Pharmaceuticals Inc.M Exercise/Conversion—
2025-12-15MISTMilestone Pharmaceuticals Inc.S Sale−$135K
2025-12-12MISTMilestone Pharmaceuticals Inc.A Award—
2025-12-12MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award—
2025-07-11MISTMilestone Pharmaceuticals Inc.A Award—
2025-07-11MISTMilestone Pharmaceuticals Inc. · Series B Common Warrants (right to buy)A Award—
2025-07-11MISTMilestone Pharmaceuticals Inc. · Series A Common Warrants (right to buy)A Award—
2025-01-27MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award—
2025-01-27MISTMilestone Pharmaceuticals Inc. · Restricted Stock UnitA Award—
2023-02-16MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award—
2022-12-05MISTMilestone Pharmaceuticals Inc.P Purchase+$32.8K
2022-12-01MISTMilestone Pharmaceuticals Inc.P Purchase+$14.6K
2022-02-15MISTMilestone Pharmaceuticals Inc. · Employee Stock Option (right to buy)A Award—

Recent filings

8

Companies

1

Address

C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD, STE 420

MONTREAL, A8, H4M 2X6